-
Praxis Aug 2022
Topics: Atrial Fibrillation; Humans
PubMed: 35975417
DOI: 10.1024/1661-8157/a003916 -
Acta Cardiologica May 2023
Topics: Humans; Atrial Fibrillation
PubMed: 37158664
DOI: 10.1080/00015385.2023.2205277 -
JACC. Clinical Electrophysiology May 2021
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Physicians; Registries
PubMed: 34016389
DOI: 10.1016/j.jacep.2020.11.025 -
Cardiovascular Research Jun 2021
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium; Coronary Artery Bypass; Humans
PubMed: 34051084
DOI: 10.1093/cvr/cvab185 -
Europace : European Pacing,... Feb 2023
Topics: Humans; Atrial Fibrillation; Heart Failure
PubMed: 36576343
DOI: 10.1093/europace/euac255 -
Europace : European Pacing,... May 2020
Topics: Aftercare; Anticoagulants; Atrial Fibrillation; Cardiology; Emergency Service, Hospital; Humans; Patient Discharge; Stroke; Treatment Outcome
PubMed: 32282897
DOI: 10.1093/europace/euz359 -
Annals of Cardiac Anaesthesia 2020Atrial fibrillation is the most common cardiac arrhythmia in western society affecting more than 35 million individuals worldwide annually. It is a common postoperative... (Review)
Review
Atrial fibrillation is the most common cardiac arrhythmia in western society affecting more than 35 million individuals worldwide annually. It is a common postoperative complication and may also occur spontaneously during general and local anesthesia administration. Aging, diabetes mellitus, hypertension, and cardiovascular diseases including cardiomyopathies, congenital cardiac anomalies, heart failure, myocardial ischemia, pericarditis, previous cardiac surgery, vascular disease, and valvular heart disease are some correlated factors. Beyond age, increased incidence of atrial fibrillation has been correlated to autoimmune system activation as it is the underlying mechanism of persistent atrial fibrillation development. Current research supports an association between the complement system activation and lymphocyte-pro-inflammatory cytokines release with the cardiac conduction system and atrial fibrosis. The loss of CD28 antigen from CD4+ CD28+ T lymphocytes seems to play a major role in atrial fibrillation development and prognosis. Except atrial fibrillation, a variety of additional electrocardiographic changes, resembling those with digitalis intoxication may accompany anaphylaxis and particularly Kounis syndrome. Histamine is one well-known mediator in allergic and inflammatory conditions as physiologically regulates several cardiovascular and endothelial functions with arrhythmogenic potential. The increased oxidative stress, measured by the redox potentials of glutathione, has been correlated with atrial fibrillation incidence and prevalence. The use of antazoline, a first-generation antihistamine agent used for rapid conversion of recent-onset atrial fibrillation in patients with preserved left ventricular function and for rapid atrial fibrillation termination during accessory pathway ablation denotes that anaphylaxis-induced histamine production could be the cause of atrial fibrillation at least in some instances. The anaphylaxis diagnosis in anesthesia can be challenging owing to the absence of cutaneous manifestetions such as flushing, urticaria, or angioedema. Anticoagulation for stroke prevention, rate and rhythm control medications, invasive methods such as radiofrequency ablation or cryoablation of pulmonary veins as well surgical ablation constitute the treatment basis of atrial fibrillation. Understanding the underlying mechanisms of atrial fibrillation by cardiologists, anesthesiologists and surgeons, as well as potential treatments, to optimize care is of paramount importance.
Topics: Anaphylaxis; Atrial Fibrillation; Cryosurgery; Humans; Radiofrequency Ablation
PubMed: 31929239
DOI: 10.4103/aca.ACA_100_19 -
JACC. Clinical Electrophysiology Nov 2022
Topics: Humans; Atrial Fibrillation; Heart Failure
PubMed: 36424003
DOI: 10.1016/j.jacep.2022.08.015 -
Circulation Journal : Official Journal... May 2020
Topics: Atrial Fibrillation; Atrial Premature Complexes; Catheter Ablation; Humans
PubMed: 32307356
DOI: 10.1253/circj.CJ-20-0255 -
Nature Reviews. Cardiology Feb 2017Sex-specific differences in the epidemiology, pathophysiology, presentation, prognosis, and treatment of atrial fibrillation (AF) are increasingly recognized. Women with... (Review)
Review
Sex-specific differences in the epidemiology, pathophysiology, presentation, prognosis, and treatment of atrial fibrillation (AF) are increasingly recognized. Women with AF generally experience worse symptoms, poorer quality of life, and have higher risk of stroke and death than men with AF. Effective treatment of the arrhythmia in women is critical to reduce the rate of adverse events. We review the current evidence on sex-specific differences in the utilization and outcomes of treatments for AF, including rate-control and rhythm-control strategies, and stroke-prevention therapy. In addition, we provide a critical evaluation of potential disparities and biases in health-care use that might be associated with differences in the outcomes between women and men. We underscore current knowledge gaps that need to be addressed in future studies to improve the management of AF in women. In particular, we suggest several strategies to produce high-quality evidence from randomized clinical trials for women with AF.
Topics: Atrial Fibrillation; Female; Humans; Patient Care Management; Prognosis; Quality of Life; Sex Factors
PubMed: 27786235
DOI: 10.1038/nrcardio.2016.171